In an adult patient with a resectable extremity or trunk‑wall soft‑tissue sarcoma and no prior radiation, what are the indications for preoperative versus postoperative radiation therapy, and when should brachytherapy be added and why?

Preoperative vs Postoperative Radiotherapy in Soft Tissue Sarcoma

Both preoperative and postoperative radiotherapy are equally acceptable for resectable extremity/trunk soft tissue sarcomas, but preoperative RT (50 Gy) is preferred for upper extremity tumors and when preservation of critical neurovascular structures is needed, while postoperative RT (50-66 Gy) is preferred for lower extremity tumors to minimize wound complications. 1, 2

Standard Indications for Radiotherapy

Radiotherapy combined with wide excision is standard treatment for:

• High-grade (G2-3), deep lesions >5 cm 3, 1
• High-grade, deep lesions <5 cm (with multidisciplinary discussion) 3

RT may be omitted for:

• G1, R0, <5 cm, superficial tumors 1
• Truly compartmental resections with tumor entirely contained within compartment 3, 2

Preoperative RT: Advantages and Disadvantages

Advantages:

• Smaller treatment volume (no need to cover entire operative field) 4
• Reduced seeding during surgical manipulation 4
• Thickening of pseudocapsule, easing resection 4
• Better offset of negative prognostic impact of R1 margins compared to postoperative RT 2
• Lower long-term morbidity: reduced fibrosis, edema, bone fracture, and joint stiffness 5, 2

Disadvantages:

• Higher acute wound complications (35% vs 17% postoperative) 5, 6
• Particularly problematic in lower extremity tumors (43% wound complications) vs upper extremity (5%) 5

Dosing:

• 50 Gy in 25 fractions 3, 4, 2
• Surgery performed 4-6 weeks after completion 1, 4

Postoperative RT: Advantages and Disadvantages

Advantages:

• Lower acute wound complications (17% vs 35% preoperative) 5, 6
• Allows definitive pathologic assessment before RT planning 4

Disadvantages:

• Larger treatment volume (must cover entire operative field) 4
• Higher long-term morbidity: increased fibrosis, edema, and functional impairment 5, 2
• Less effective at compensating for positive margins 2

Dosing:

• 50-60 Gy base dose (1.8-2 Gy fractions) 3
• Boost to 66 Gy depending on margin status 3, 4
• Initiated 3-8 weeks after surgery once wound healing complete 4

Anatomic Site-Specific Recommendations

Upper extremity tumors: Favor preoperative RT given low wound complication risk (5%) and reduced long-term morbidity 5

Lower extremity tumors (especially upper thigh): Favor postoperative RT due to high wound complication risk (43%) with preoperative approach 5

Head and neck locations: Postoperative RT preferred 1

When to Add Brachytherapy

Brachytherapy is added as a boost for positive or close margins in the following scenarios:

After Preoperative RT:

• 12-20 Gy brachytherapy boost delivered several days after surgery through catheters placed intraoperatively, based on final margin status 4
• Alternative: Single intraoperative dose of 10-16 Gy immediately after resection 4

After Postoperative RT Alone:

• 45 Gy low-dose-rate brachytherapy for negative margins 4
• 16-20 Gy low-dose-rate brachytherapy (or high-dose-rate equivalent) for positive margins, followed by external beam RT to 50 Gy 4

Why Brachytherapy is Added:

• Direct application to tumor bed allows precise dose delivery to high-risk areas 4
• Minimizes dose to surrounding normal tissues 4
• Particularly useful when margins are close due to proximity to major neurovascular bundles or bone 4
• Requires catheters placed at operation for optimal geometry 7

Critical Pitfalls to Avoid

1. Do not use preoperative RT for lower extremity tumors without plastic surgery consultation - wound complication rates are prohibitively high 4, 5

2. Do not delay surgery >6 weeks after preoperative RT - increases wound complications 1, 4

3. Do not delay postoperative RT excessively - late fibrosis develops, though 3-8 weeks needed for wound healing 4

4. RT does not compensate for inadequate surgery - re-excision at reference center is mandatory for R2 resections 3, 1

5. Brachytherapy requires specific expertise - should only be used when satisfactory geometry can be achieved 7

Key Evidence Considerations

The Canadian SR2 trial 5, 6 demonstrated equivalent local control and survival between preoperative and postoperative RT, but with different toxicity profiles. This landmark study guides the anatomic site-specific recommendations above. The most recent guidelines 1, 2 from 2021-2022 emphasize that preoperative RT better offsets the negative impact of R1 margins, which is particularly relevant when preservation of critical structures is the surgical goal.

RT improves local control but not overall survival - this fundamental principle means treatment decisions must balance oncologic control against functional outcomes and quality of life 3.